We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

000660:KRXSK hynix Inc. Analysis

Data as of 2026-07-28 - not real-time

₩1,591,000.00

Latest Price

8/10Risk

Risk Level: High

Executive Summary

SK hynix is trading at roughly KRW 1.59 million, well below its 20‑day SMA of KRW 2.05 million and the 50‑day SMA of KRW 2.19 million, indicating short‑term weakness. RSI sits at 36.9, suggesting the stock is approaching oversold territory, while the MACD is in a bearish crossover with a negative histogram. The forward P/E of 3.53 is dramatically lower than the semiconductor industry average of 32.6, pointing to a valuation gap, although the DCF‑derived fair value of about KRW 1.32 million is modestly below the current price. Volatility is extreme at 124% over the past 30 days and beta exceeds 1.6, reflecting high market sensitivity and a recent max drawdown of –45%. The company boasts extraordinary profitability – ROE over 60% and operating margin above 71% – and a strong cash position, but carries a high debt‑to‑equity ratio of 13.3. Recent material news includes a landmark U.S. ADR listing raising up to $28 billion and inclusion in the MSCI Emerging Markets Index, both of which could broaden the investor base and add upward pressure.
In the medium term, the stock faces sector‑cyclical headwinds and a bearish technical backdrop, yet its fundamentals remain robust with low payout (≈2.8%) and a sustainable dividend yield of 0.17%. The combination of undervalued multiples, strategic capital‑raising moves, and dominant market position in DRAM/NAND supports a longer‑run upside thesis, while the high beta and liquidity contraction keep risk elevated.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 6/10

Key Factors

  • Price near support at KRW 1.577 million
  • US ADR listing expands capital and investor reach
  • RSI indicating potential oversold condition

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Strong cash flow and ROE underpin earnings stability
  • High beta and sector volatility may limit gains
  • Inclusion in MSCI EM index could attract passive inflows

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Long‑term demand growth for DRAM and NAND memory
  • Undervalued multiples relative to industry peers
  • Strategic US listing enhances global visibility and financing options

Key Metrics & Analysis

Financial Health

Revenue Growth198.10%
Profit Margin56.89%
P/E Ratio3.5
ROE61.17%
ROA27.89%
Debt/Equity13.28
Op. Cash Flow₩70679.6B
Free Cash Flow₩25809.1B
Industry P/E32.6

Technical Analysis

TrendNeutral
RSI36.9
Support₩1,577,000.00
Resistance₩2,742,000.00
MA 20₩2,050,250.00
MA 50₩2,188,420.00
MA 200₩1,158,712.50
MACDBearish
VolumeDecreasing
Fear & Greed Index88.09

Valuation

Fair Value₩1,315,591.98
Target Price₩3,408,502.20
Upside/Downside114.24%
GradeFair
TypeBlend
Dividend Yield0.17%

Risk Assessment

Beta1.63
Volatility124.04%
Sector RiskHigh
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.